Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Biorestorative Therapies, Inc. (BRTX) had Operating Cash Flow per Share of $-0.63 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.30M |
|
$-2.66M |
|
$0.01M |
|
$0.29M |
|
$3.61M |
|
$-3.31M |
|
$0.65M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-3.31M |
|
$-3.25M |
|
8.74M |
|
8.74M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$7.60M |
|
$0.34M |
|
$0.92M |
|
$8.52M |
|
$3.67M |
|
-- |
|
-- |
|
$3.67M |
|
$4.83M |
|
$4.27M |
|
$4.85M |
|
7.98M |
|
| Cash Flow Statement Financials | |
$-5.47M |
|
$4.50M |
|
$1.98M |
|
$0.55M |
|
$1.56M |
|
$1.01M |
|
$2.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
97.12% |
|
-1089.78% |
|
-1089.78% |
|
-- |
|
-875.79% |
|
-875.79% |
|
$-5.51M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
20.22 |
|
4.45 |
|
-54.98% |
|
-62.26% |
|
-31.19% |
|
-54.82% |
|
$0.61 |
|
$-0.63 |
|
|
Operating Cash Flow per Share |
$-0.63 |